Total Payments
$7,229
2024 Payments
$1,181
Companies
18
Transactions
494
Medicare Patients
357
Medicare Billing
$36,544
Payment Breakdown by Category
Food & Beverage$7,178 (99.3%)
Education$50.90 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,178 | 490 | 99.3% |
| Education | $50.90 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,534 | 89 | $0 (2024) |
| Alkermes, Inc. | $1,335 | 65 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $939.37 | 67 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $689.12 | 53 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $483.55 | 39 | $0 (2024) |
| ABBVIE INC. | $481.00 | 37 | $0 (2024) |
| Allergan, Inc. | $425.69 | 65 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $421.43 | 35 | $0 (2022) |
| ITI, Inc. | $216.34 | 13 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $208.75 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,181 | 59 | Teva Pharmaceuticals USA, Inc. ($306.05) |
| 2023 | $848.09 | 57 | Neurocrine Biosciences, Inc. ($259.09) |
| 2022 | $1,414 | 89 | Janssen Pharmaceuticals, Inc ($315.08) |
| 2021 | $916.90 | 71 | Janssen Pharmaceuticals, Inc ($195.04) |
| 2020 | $253.39 | 18 | Janssen Pharmaceuticals, Inc ($133.96) |
| 2019 | $691.73 | 43 | Otsuka America Pharmaceutical, Inc. ($121.06) |
| 2018 | $891.23 | 63 | Alkermes, Inc. ($295.36) |
| 2017 | $1,032 | 94 | Janssen Pharmaceuticals, Inc ($388.34) |
All Payment Transactions
494 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.05 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.85 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $107.90 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: CNS | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: CNS | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Neuropsychiatry | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.99 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $116.54 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: CNS | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| 10/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: CNS | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Central Nervous System | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $0.37 | General |
| Category: Central Nervous System | ||||||
| 10/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 116 | 272 | $36,466 | $13,289 |
| 2022 | 6 | 129 | 246 | $35,800 | $13,612 |
| 2021 | 6 | 112 | 175 | $23,260 | $9,643 |
Total Patients
357
Total Services
693
Medicare Billing
$36,544
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 105 | $24,408 | $8,907 | 36.5% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 16 | 23 | $6,095 | $2,229 | 36.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 113 | $2,825 | $998.45 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 16 | $1,890 | $960.40 | 50.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 15 | $1,248 | $194.11 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 98 | $24,422 | $8,442 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 31 | $3,899 | $1,884 | 48.3% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 11 | 16 | $2,225 | $1,562 | 70.2% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 11 | 13 | $2,275 | $938.55 | 41.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 41 | 75 | $1,875 | $623.07 | 33.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 13 | 13 | $1,104 | $162.00 | 14.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 48 | $11,903 | $4,183 | 35.1% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2021 | 11 | 17 | $2,937 | $2,154 | 73.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 25 | $3,189 | $1,395 | 43.7% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 12 | 16 | $2,800 | $1,262 | 45.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 32 | 55 | $1,375 | $472.56 | 34.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 12 | 14 | $1,056 | $177.58 | 16.8% |
About Dr. James Riddle, MD
Dr. James Riddle, MD is a Psychiatry healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225003973.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Riddle, MD has received a total of $7,229 in payments from pharmaceutical and medical device companies, with $1,181 received in 2024. These payments were reported across 494 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($7,178).
As a Medicare-enrolled provider, Riddle has provided services to 357 Medicare beneficiaries, totaling 693 services with total Medicare billing of $36,544. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Columbia, SC
- Active Since 02/17/2006
- Last Updated 07/09/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1225003973
Products in Payments
- INVEGA SUSTENNA (Drug) $1,072
- INGREZZA (Drug) $919.39
- VRAYLAR (Drug) $866.70
- ARISTADA (Drug) $648.69
- Aristada 441 mg (Drug) $449.42
- LATUDA (Drug) $421.43
- INVEGA TRINZA (Drug) $392.62
- ABILIFY MAINTENA (Drug) $333.74
- AUSTEDO (Drug) $255.91
- REXULTI (Drug) $250.82
- UZEDY (Drug) $243.08
- LYBALVI (Drug) $236.66
- CAPLYTA (Drug) $216.34
- Austedo XR (Drug) $180.02
- COBENFY (Drug) $171.43
- Fanapt (Drug) $156.44
- TRINTELLIX (Drug) $113.02
- SPRAVATO (Drug) $69.44
- HETLIOZ (Drug) $39.61
- NAMZARIC (Drug) $31.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Columbia
Dr. Meera Narasimhan, M.d, M.D
Psychiatry — Payments: $57,045
Psychiatry $57,045
Dr. Joseph Parks, M.d, M.D
Psychiatry — Payments: $53,504
Psychiatry $53,504
Agara Reddy, Md, MD
Psychiatry — Payments: $15,068
Psychiatry $15,068
Deborah Leverette, Md Mph, MD MPH
Psychiatry — Payments: $12,750
Psychiatry $12,750
Gariane Gunter, M.d, M.D
Psychiatry — Payments: $11,480
Psychiatry $11,480
Dr. Nioaka Campbell, M.d, M.D
Psychiatry — Payments: $10,898
Psychiatry $10,898